On April 20, the economic performance for the first quarter in Beijing Yizhuang was officially released. Data shows that Yizhuang New City achieved a regional Gross Domestic Product (GDP) of 95.67 billion yuan in the first quarter, a year-on-year increase of 6.2% (calculated at constant prices). Multiple indicators reflecting high-quality development, such as investment in high-tech industries and R&D expenses of large and medium-sized key enterprises, maintained double-digit growth. This demonstrates a stable and progressive, continuously positive development momentum, delivering a solid report card for the first quarter of the "16th Five-Year Plan" period.
An industrial foundation serves as the core engine for economic development. In the first quarter, Beijing Yizhuang's industrial added value increased by 5.9% year-on-year, further consolidating its role as the ballast for the capital's real economy. Structurally, leading industries continued to show strong momentum. New corporate achievements emerged rapidly, leading industry upgrades. For example, Changmugu's globally first "six-in-one" AI-powered full orthopedic surgical robot platform, ROPA6, received market approval. Concurrently, landmark projects advanced orderly, expanding the industrial landscape. Key structures of the Sanofi insulin API project are expected to take shape by year-end, and the High-End Auto Parts Industrial Park officially commenced construction.
Particularly notable is Beijing Yizhuang's new breakthrough in promoting industrial structure optimization and upgrading. New growth drivers are being accelerated, providing solid support for regional economic growth. In the first quarter, producer services displayed strong growth vitality. Revenues from information services, scientific and technical services, and leasing and business services all maintained rapid growth. Two key net revenue streams in the financial sector achieved double-digit growth, rising 25% year-on-year.
Innovation-driven development enhances economic resilience. From January to February, R&D expenses of large and medium-sized key enterprises in Beijing Yizhuang reached 11.89 billion yuan, a year-on-year increase of 33.2%, leading growth rates citywide. The data indicates that innovation has become a key factor for enterprises in the zone to enhance core competitiveness. Sustained increases in R&D investment are continuously being translated into a vital source for industrial development, promoting the deep integration of technological innovation and industrial innovation.
Behind the continuous breakthroughs and practical application of cutting-edge technologies lies Beijing Yizhuang's systemic approach and precise policies, focused on building a "rainforest-style" innovation ecosystem. This forms a full-cycle support chain encompassing incubation platforms, cultivation models, and policy systems. Currently, as the main platform for the "Three Cities and One Area" initiative in building the Beijing-Tianjin-Hebei International Science and Technology Innovation Center, Beijing Yizhuang insists on leading industrial innovation with scientific and technological innovation. Since the start of the "14th Five-Year Plan" period, it has undertaken and commercialized over 1,200 scientific and technological achievements from the "Three Cities," with the "Core Technology Project" achieving breakthroughs in over a hundred key technologies.
Forward-looking planning outlines the future blueprint for economic development. This year marks the beginning of the "16th Five-Year Plan" period. Looking ahead, Beijing Yizhuang is adopting a longer-term strategic vision and more systematic planning. By optimizing industrial layout and strengthening policy support, it aims to chart a future blueprint for high-quality regional economic development, striving to extend the strong start of the first quarter into sustained success throughout the year.
In optimizing the industrial layout, Beijing Yizhuang is accelerating the construction of the International BioPark. This platform aims to attract and aggregate global innovation resources in medicine and health. Since the beginning of the year, the Harbour BioMed-AstraZeneca innovation lab and Bristol Myers Squibb's first innovation center in China have successively become operational. Supporting talent rental housing projects are also progressing rapidly. Furthermore, the Yizhuang Comprehensive Bonded Zone is becoming a frontline for Beijing Yizhuang to deepen its openness to the world, with the first batch of processing and R&D industrial space projects passing final inspection and acceptance in the first quarter.
Regarding policy guidance, in the first quarter, Beijing Yizhuang introduced special policies to support Brain-Computer Interface (BCI) development. These policies outline 15 specific measures focusing on tackling key technological products, building innovation carriers, and cultivating the industrial ecosystem, aiming to seize opportunities in BCI innovation and industrial transformation. A full-chain policy framework is in place to drive technological breakthroughs and application deployment. In this field, Beijing Yizhuang has already achieved landmark results. The Beijing Frontier Brain-Computer Interface Research Institute has been established and is expected to become operational in the second half of the year, aiming to accelerate the clinical translation of BCI technologies for patient benefit.
A relevant official from the Beijing Economic-Technological Development Area's Economic Development Bureau stated, "The solid first-quarter results provide a good start for Beijing Yizhuang's high-quality development during the '16th Five-Year Plan' period. Moving forward, we will continue to strengthen innovation-driven development, build a modern industrial system, promote diversified growth in leading and future industries, and accelerate the cultivation and expansion of new quality productive forces, contributing more from Yizhuang to the high-quality development of the capital's economy."
Comments